Breakthrough science to advance human health and perfromance

Scroll to explore

Mission

Advance quality of life for 1 000 000 000 people

Trusted by +100 Internationally Recognized Institutions

We speak the languageof the brain and body

01010111 01100101 00100000 01110011 01110000 01100101 01100001 01101011 0010000001110100 01101000 01100101 00100000 01101100 01100001 01101110 01100111 0111010101100001 01100111 01100101 00100000 01101111 01100110 00100000 01110100 0110100001100101 00100000 01100010 01110010 01100001 01101001 01101110 00100000 0110000101101110 01100100 00100000 01100010 01101111 01100100 01111001 00101110 0010000001010100 01101000 01100101 00100000 01100010 01110010 01100001 01101001 0110111000100000 01100001 01101110 01100100 00100000 01100010 01101111 01100100 01111001

Parasym has unlocked precise neural targets with wide application+

Scientific breakthroughs

57%

Improvement in learning acquisition

Applicable to all applications of human learning. [ 1 ]

61.9%

Improvement in Parasympathetic response in 5 minutes

Known as the 'Rest and Digest' response, modulating this function can help deliver significant calm, focus and recovery on demand. [ 2 ]

85%

Reduction in cardiac arrhythmia

Heart disease is the world's leading cause of death and disability. Arrhythmia is a type of heart disease characterised by irregularity in heart rhythm. [ 3 ]

Fine tuning anti-tumor immune responses in cancer therapy

The immune system plays a crucial role in recognizing and eliminating cancer cells, but traditional therapies often broadly activate or suppress it across the body, leading to toxic side effects. Parasym technology finely tunes the response, amplifying desirable anti-tumor signals while muting counterproductive ones for precision elimination of cancer cells. [ 4 ]

Advancing

$10M+

Invested in science and clinical trials

10+

Years of Parasym R&D

50+

Completed clinical studies

100+

Elite research institutions partners

4M+

Completed treatment sessions

Neural targets unlocked

Access Parasym

[email protected]

Trusted by +100 Internationally Recognized Institutions

Gold standard study design. Parasym's technology selectively enhances long-term retention of learned second-language vocabulary (active compared to placebo at 7-day recall). Data from a randomized, placebo controlled, blinded neurolinguistic study using Parasym technology in typically developing young adults for language learning.

*Gold standard clinical study design. Parasym's technology selectively enhances parasympathetic activity (>50% increase in high-frequency HRV after 5 minute treatment vs Placebo) with results persisting into recovery. Data from a randomized, placebo controlled, double blinded trial using Parasym technology in healthy young adults, measured using medical grade ECG.

Gold standard clinical study design. Parasym's technology significantly reduced Atrial Fibrillation (AF) burden by 85% in patients with Paroxysmal AF. Data from randomized, placebo-controlled, blinded clinical trial using Parasym's technology, measured via medical grade ECG patches over six months.

Gold standard pre clinical study design. Parasym's technology selectively enhances desirable anti-tumor signals (CD8+ T cell activation, IFN-γ/CD137 upregulation) while suppressing counterproductive immune signaling (blunting RT-induced IFN-γ overproduction and reducing regulatory T cells). Data from an immunological study using Parasym technology in a murine Lewis lung carcinoma model.

The brain and body communicate via electrical signals.

By sending precise targeted bioelectric signals to the brain, it's possible to modulate critical processes that control health and performance.

Parasym's ongoing research spans across all major health and performance applications in 100+ ongoing clinical studies. These range from the world's leading cause of death and disability, to enhanced performance and learning for world number 1 sports teams, to programs with national Special Forces.